Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome

Benadiva, Claudio; Davis, Owen K.; Kligman, Isaac; Moomjy, Maureen; Liu, Hung-Ching; Rosenwaks, Zev

doi:10.1016/s0015-0282(97)81373-8

Cited by 102 publications

(54 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Coasting is a valuable strategy for OHSS prevention but has recognized limitations, because it does not eliminate OHSS and may result in compromised cycle outcomes (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(41)(42)(43). Because OHSS may lead to dangerous and potentially fatal sequelae, complete prevention of this complication would be ideal.…”

mentioning

confidence: 99%

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

Diluigi

Engmann

Schmidt

et al. 2010

Fertility and Sterility

Self Cite

View full text Add to dashboard Cite

mentioning

confidence: 99%

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

Diluigi

Engmann

Schmidt

et al. 2010

Fertility and Sterility

Self Cite

View full text Add to dashboard Cite

“…Furthermore, it is well known that chorionic gonadotrophins or lutenising hormone (LH) surge are important in triggering OHSS in those receiving either exogenous gonadotrophins or stimulated by clomiphene citrate (23). However, as we had no means of measuring the lady's LH levels at the onset of her symptoms it will be impossible to know if the OHSS in this case resulted from LH surge or not.…”

Section: Discussionmentioning

confidence: 91%

Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer

Baigent

Lashen

2011

Fertility and Sterility

View full text Add to dashboard Cite

“…Our study showed that the rate of retrieved oocytes was lower in coasting cycles than in previously treated cycles. Recent studies suggest that although the number of oocytes was significantly lower in the coasting cycle, coasting did not affect the pregnancy rate [11,12].…”

Section: Discussionmentioning

confidence: 94%

Coasting May Reduce the Severity of the Ovarian Hyperstimulation Syndrome in Patients with Polycystic Ovary Syndrome

Ohata

Harada²,

Ito³

et al. 2000

Gynecol Obstet Invest

View full text Add to dashboard Cite

The aim of our study was to determine the efficacy of postponing administration of human chorionic gonadotropin while continuing daily gonadotropin-releasing hormone agonist therapy (‘coasting’) to prevent the occurrence of severe ovarian hyperstimulation syndrome (OHSS) for patients with polycystic ovary (PCO) syndrome. Five patients with PCO who had been hospitalized due to severe OHSS in previous in vitro fertilization and embryo transfer or intrauterine insemination cycles at the Tottori University Hospital were included in the study. The rates of mature oocytes and fertilization were comparable between the cycles. A singleton pregnancy was achieved in a patient during the coasting cycle, and none of the women developed severe OHSS in coasting cycles. The results suggest that coasting may be an alternative method for reducing the severity of OHSS in patients with PCO.

show abstract

Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome

Cited by 102 publications

References 11 publications

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer

Coasting May Reduce the Severity of the Ovarian Hyperstimulation Syndrome in Patients with Polycystic Ovary Syndrome

Contact Info

Product

Resources

About